Home β€Ί Stock analysis β€Ί IPHA

Innate Pharma SA (IPHA) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

IPHA slides 3.4% to $1.43. Closed at $1.43, -3.38% vs the prior close of $1.48. Day range $1.43–$1.53, opened at $1.53.

Last close$1.43-3.38%
Day range1.43–1.53
Open1.53
Volume8.03K
52-week range1.17–2.71
Avg volume (20d)42.85K

IPHA daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” IPHA slides 3.4% to $1.43
Oct 15, 2026 β€” IPHA jumps 3.5% to $1.48
Oct 14, 2026 β€” IPHA dips 2.7% to $1.43, a 3-month low, 3 down days in a row
Oct 13, 2026 β€” IPHA dips 0.7% to $1.47, a 3-month low
Oct 12, 2026 β€” IPHA slides 8.6% to $1.48
Oct 9, 2026 β€” IPHA jumps 9.5% to $1.62
Oct 8, 2026 β€” IPHA dips 2.6% to $1.48, a 3-month low
Oct 7, 2026 β€” IPHA slides 4.4% to $1.52, a 3-month low
Oct 6, 2026 β€” IPHA rises 0.6% to $1.59
Oct 5, 2026 β€” IPHA rises 1.3% to $1.58
Oct 2, 2026 β€” IPHA dips 1.9% to $1.56, a 3-month low

IPHA latest news & SEC filings

Every SEC filing by or about IPHA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Sep 17, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001628280-26-062360

Sep 17, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001598599-26-000010

Sep 17, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001628280-26-062357

Sep 10, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001628280-26-061214

Sep 2, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001628280-26-059963

Aug 19, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001628280-26-057935

Aug 14, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001628280-26-056913

Aug 10, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001628280-26-054966

Jul 23, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001628280-26-049273

Jul 21, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001598599-26-000008

Jun 22, 2026 Β· Form SCHEDULE 13G/A β€” Update to a passive 5%+ stake (13G)

Update to a passive 5%+ stake (13G)

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0000950103-26-009261

Things to know before you trade IPHA

IPHA market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 20261.531.531.431.438.03K
Oct 15, 20261.471.581.461.487.20K
Oct 14, 20261.441.471.421.439.30K
Oct 13, 20261.471.481.451.475.60K
Oct 12, 20261.481.531.461.4833.80K
Oct 9, 20261.491.681.491.6246.90K
Oct 8, 20261.501.541.471.4818.40K
Oct 7, 20261.541.551.501.5213.80K
Oct 6, 20261.581.651.531.59133.70K
Oct 5, 20261.541.691.531.58106.90K
Oct 2, 20261.561.691.531.5692.70K
Oct 1, 20261.601.671.581.5963.90K
Sep 30, 20261.611.781.611.6337.80K
Sep 29, 20261.631.661.591.6031.80K
Sep 28, 20261.711.791.661.7042.10K
Sep 25, 20261.671.701.611.7031.00K
Sep 24, 20261.721.731.691.7017.70K
Sep 23, 20261.811.811.761.7623.70K
Sep 22, 20261.841.841.771.8055.70K
Sep 21, 20261.861.861.791.8677.00K

About Innate Pharma SA

Innate Pharma SA (IPHA) is listed on the Nasdaq and classified by the SEC under β€œBiological Products, (No Diagnostic Substances)”. Its business address is in MARSEILLE. State of incorporation: France. Fiscal year ends December 31. SEC CIK 1598599.

IPHA board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Executive officers

NameTitleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Recent insider buys & sales

DateInsiderTypeSharesPrice
No open-market insider buys or sales reported in the last 12 months.

IPHA financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
No annual XBRL figures available (foreign filers often report on Form 20-F).

Latest balance sheet: total assets $β€”, total liabilities $β€”, cash $β€”.

IPHA earnings / results-day log

DateFilingClose that day
No 8-K earnings releases in recent filings.

Related stocks Β· Biological Products, (No Diagnostic Substances)

Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on IPHA

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.